Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics società ha sostenuto
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions leggi di più
The decision to come work here earlier this year has been a very positive one
Cosa ti piace di più del team di leadership?
Too new an emplpyee to comment
Qual è la parte migliore del tuo compenso?
Strong Medical coverage, vacation policy, company 401k match
Che cosa ti rende più felice sul posto di lavoro?
Engaging colleagues, to meet their needs
La cosa più positiva della cultura e l'ambiente presso la tua azienda?
The company's commitment to patients
Other Employee Reviews for Karyopharm Therapeutics
×